[O2] Oral Presentations 2 | Symposium of AMED SCARDA Japan Initiative for World-leading Vaccine Research and Development Centers

Advanced Search

Session Details

Oral Presentations

[O2]Oral Presentations 2

Tue. Mar 3, 2026 8:30 AM - 9:30 AM JST
Tue. Mar 3, 2026 11:30 PM - 12:30 AM UTC

Kobe Portopia Hotel(South Wing 1F Ohwada)

【R&D I】

8:30 AM - 8:40 AM JST(11:30 PM - 11:40 PM UTC)R&D IVirology

[O2-01]Development of a Therapeutic Live-Attenuated HSV-2 Vaccine

*YASUSHI KAWAGUCHI¹ (1. The UTOPIA Center, The University of Tokyo (Japan))

Comment()

8:40 AM - 8:50 AM JST(11:40 PM - 11:50 PM UTC)R&D IVaccine Science

[O2-02]Development of a Live Attenuated Tetravalent Dengue Vaccine (KD-382)

*Motoharu Abe¹ (1. DEJIMA Infectious Disease Research Alliance, Vaccine Research and Development Center, Nagasaki University (Japan))

Comment()

8:50 AM - 9:00 AM JST(11:50 PM - 12:00 AM UTC)R&D IVirology

[O2-03]Next-Generation Cross-Protective Vaccine Technology Against Dengue and Zika Based on T Cell–Mediated Immune Responses

*Meng Ling Moi^1,2 (1. Graduate School of Medicine, the University of Tokyo (Japan), 2. The UTOPIA Center, The University of Tokyo (Japan))

Comment()

9:00 AM - 9:10 AM JST(12:00 AM - 12:10 AM UTC)R&D IVaccine ScienceCandidate for the Oral Presentation Award for Early-career Researchers

[O2-04E]Development of the influenza/COVID-19 combined vaccine and its importance

*Marumi Ohno^1,2,3, Chimuka Handabile^1,2, Richard Obeng-Kyeremeh¹, Minori Haruta¹, Toshiki Sekiya^1,2,4, Tomomi Kawakita¹, Naoki Nomura¹, Masashi Shingai^1,2, Hiroshi Kida^1,2 (1. International Institute for Zoonosis Control, Hokkaido University (Japan), 2. Institute for Vaccine Research and Development (IVReD), Hokkaido University (Japan), 3. One Health Research Center, Hokkaido Univeristy (Japan), 4. Peter Doherty Institute, Melbourne University (Australia))

Comment()

9:10 AM - 9:20 AM JST(12:10 AM - 12:20 AM UTC)R&D IVirology

[O2-05]Development of a live attenuated vaccine against SFTS

*Jiro Yasuda¹ (1. VRDC, Nagasaki University (Japan))

Comment()

9:20 AM - 9:30 AM JST(12:20 AM - 12:30 AM UTC)R&D IVirology

[O2-06]Development of Effective and Safe Vaccines for SARS-CoV-2, Ebola virus, and influenza viruses based on single cycle replicating viruses

*Yoshihiro Kawaoka¹ (1. UTOPIA (Japan))

Comment()

Back to Category List